Compound research

GHK-Cu (Copper Tripeptide-1): Research Overview

Aminent Labs Research·Updated July 2026·For Research Use Only·5 min read

GHK-Cu is the copper(II) complex of the naturally occurring tripeptide glycyl-L-histidyl-L-lysine (GHK). It has been the subject of extensive in-vitro, animal-model, and cosmetic-science research since its identification in the 1970s. This overview summarizes the reported biochemistry and the research contexts in which GHK-Cu has been studied, and is intended solely for laboratory and educational reference. GHK-Cu supplied for research is a research-use-only (RUO) material and is not a drug, dietary supplement, or cosmetic sold for human use.

What is GHK-Cu?

GHK-Cu is the copper(II) coordination complex of the tripeptide glycyl-L-histidyl-L-lysine (sequence Gly-His-Lys, abbreviated GHK). In cosmetic-ingredient nomenclature (INCI) the copper complex is designated copper tripeptide-1, while GHK-Cu is the shorthand used in the peer-reviewed literature. The free tripeptide has a molecular weight of approximately 340 g/mol; the copper-bound complex is commonly cited at a molecular weight of roughly 403.9 g/mol, reflecting coordination of a single Cu²⁺ ion.

The peptide was first described by Loren Pickart in 1973 as a factor isolated from human albumin. GHK occurs naturally in human plasma and other tissues, where it is reported to bind copper(II) with high affinity. A frequently cited observation in the literature is that plasma GHK concentrations decline with age. These are descriptive biochemical characterizations of an endogenous molecule, not claims regarding any product or human application.

Mechanisms studied in research

Mechanistic work on GHK-Cu has been conducted primarily in cell-culture and biochemical systems. Reported and investigated mechanisms include:

Copper coordination and transport. GHK is studied as a copper-binding ligand, and researchers have investigated whether it can serve as a carrier that modulates the availability of copper(II) to cells in vitro.
Gene-expression modulation. Transcriptomic studies in cultured cells have reported that GHK-Cu is associated with altered expression of a large number of human genes, including pathways connected to extracellular-matrix turnover and cellular stress responses.
Collagen and extracellular-matrix (ECM) pathways. In fibroblast culture, GHK-Cu has been investigated for its association with the synthesis of collagen, elastin, proteoglycans, and glycosaminoglycans.
Antioxidant-related pathways. Research has examined GHK-Cu in the context of antioxidant enzyme activity and reactive-oxygen-species handling in experimental models.

These points describe mechanisms investigated in vitro and in preclinical systems. They are reported research findings, not established effects in humans, and no therapeutic action in people should be inferred.

Areas of preclinical and cosmetic-science investigation

The GHK-Cu literature spans several research areas. In animal wound-healing models, topical GHK-Cu has been studied for its association with wound contraction, epithelialization, angiogenesis, and organized matrix deposition relative to vehicle and untreated controls. Proposed mediators discussed in this preclinical literature include growth factors such as TGF-beta, VEGF, and FGF within experimental models.

In dermatological and cosmetic-science research, copper tripeptide-1 has been examined in the context of skin fibroblast behavior, ECM remodeling, and formulation studies. Additional preclinical investigation has touched on hair-follicle biology, connective-tissue and bone-repair models, and anti-inflammatory signaling in laboratory systems.

Across all of these areas, the evidence base is predominantly in-vitro and animal-model work; large controlled human trials of systemic GHK-Cu are not established. These are strictly research contexts and do not represent demonstrated outcomes or intended uses in people.

Stability, handling & storage

Research-grade GHK-Cu is typically supplied as a lyophilized (freeze-dried) solid, often as a blue-tinted powder owing to the coordinated copper(II) ion. General laboratory practice for peptides of this class is to store the lyophilized material sealed and desiccated at low temperature (commonly -20 C or colder for long-term storage), protected from light, humidity, and repeated temperature cycling. The copper complex can be sensitive to oxidative and photochemical conditions, and pH extremes may affect copper coordination, so buffered handling is common in experimental work.

For in-vitro use, peptides are generally brought into solution using laboratory-appropriate solvents and then aliquoted to minimize freeze-thaw cycles. These are general laboratory-handling considerations for benchtop research only. This page provides no reconstitution, dosing, or administration guidance for humans or animals, and none should be inferred.

How research-grade peptides are characterized

Quality characterization is central to reproducible peptide research. Analytical methods commonly applied to materials such as GHK-Cu include:

Reversed-phase HPLC to assess chromatographic purity and detect process- or storage-related impurities.
Mass spectrometry (e.g., ESI-MS or MALDI-TOF) to confirm molecular identity and expected mass, including verification of the copper-complexed species where applicable.
Additional identity and content assays, which may include peptide-content determination and, for copper complexes, confirmation of copper association.

A Certificate of Analysis (COA) documenting purity, identity, and lot-specific analytical data is a key reference for researchers, supporting experimental reproducibility. Reviewing the COA is standard practice before using any research-grade material in laboratory work.

How research-grade GHK-Cu is prepared

GHK-Cu is unusual among the compounds in this catalog because it is not a single covalent molecule but a coordination complex: a defined tripeptide plus a bound metal ion. Preparation therefore has two distinct stages, and a specification has to speak to both.

The peptide itself — glycyl-L-histidyl-L-lysine — is a tripeptide, among the simplest targets in solid-phase peptide synthesis, and is assembled and purified by the same route used for longer sequences. The complex is then formed by combining the purified tripeptide with a copper(II) source under controlled conditions. The copper is held by the peptide rather than covalently bonded to it, with the histidine imidazole and the peptide's N-terminal amine among the coordinating groups described in the literature. This distinction matters practically: a lot can contain the correct peptide and still be an incorrectly loaded complex, which is why identity documentation for this compound should address copper association and not peptide mass alone.

Reading a GHK-Cu certificate of analysis

The figures worth checking for this compound specifically:

Which mass is being reported. The free tripeptide is approximately 340 g/mol; the copper complex is commonly cited near 403.9 g/mol. The roughly 64-unit difference is the coordinated copper ion. A certificate quoting the lower figure is describing uncomplexed GHK — a different material from GHK-Cu — so confirming which number a report refers to is the first check.
Copper association. Because the metal is what distinguishes the complex from the bare peptide, a meaningful specification confirms copper is present and associated, rather than reporting peptide purity in isolation.
Purity by HPLC. An area-percent figure with its method stated, assessing the peptide component against synthesis-related impurities — see HPLC vs mass spectrometry for why an identity test and a purity test answer different questions.
Net peptide content. As with any lyophilized material, vial mass includes residual water and salts, so gross mass overstates the amount of compound present. Net Peptide Content vs. Purity covers the correction, which for a coordination complex also has to account for the metal's contribution to formula mass.

Per-lot reports are published on the certificates of analysis page, and lot documentation accompanies the GHK-Cu listing. How to Read a Peptide COA walks through a certificate field by field.

Points of confusion in the literature

GHK and GHK-Cu are not interchangeable names. A substantial part of the published literature studies the copper complex specifically, and attributes the observed behaviour to the complex rather than to the peptide alone. Reading a result for GHK-Cu as though it applied to uncomplexed GHK — or sourcing the bare tripeptide when the literature describes the complex — is the most common error with this compound.

"Copper peptide" is a loose term. In cosmetic-science writing the phrase is used for a range of copper-containing preparations, not solely for this tripeptide complex. When comparing sources, confirm the specific compound described rather than relying on the general label.

Colour is a qualitative cue, not an assay. The complex's characteristic blue arises from a d-d electronic absorption of the coordinated copper, which makes visible fading or a colour shift a useful informal indicator that the complex has changed. It is not a measurement. Definitive assessment still requires chromatographic and spectrometric testing, and the copper centre also makes this compound more light-sensitive than most peptides — both points are developed in Peptide Storage and Stability.

FAQ

What is GHK-Cu? GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine (GHK), known in cosmetic nomenclature as copper tripeptide-1. GHK occurs naturally in human plasma and binds copper with high affinity. It has a molecular weight of approximately 403.9 g/mol as the copper complex and has been studied extensively in in-vitro and animal research since the 1970s.

Is GHK-Cu approved for any use? GHK-Cu supplied as a research material is an unapproved research chemical. It is not an approved drug, is not a dietary supplement, and is not sold here as a cosmetic for human use. It is intended strictly for research use only (RUO) and is not for human or veterinary use, consumption, or application.

How should GHK-Cu be stored? General laboratory practice is to store lyophilized GHK-Cu sealed and desiccated at low temperature (commonly -20 C or colder for long-term storage), protected from light, moisture, and repeated temperature cycling to help preserve the copper complex. This is general handling information for benchtop research only, not usage guidance.

How is purity verified? Purity and identity of research-grade GHK-Cu are typically assessed by reversed-phase HPLC for chromatographic purity and by mass spectrometry to confirm molecular identity and mass. A lot-specific Certificate of Analysis (COA) documenting these results is the standard reference for researchers evaluating a given batch.

What is the difference between GHK and GHK-Cu? GHK is the free tripeptide glycyl-L-histidyl-L-lysine, with a molecular weight of approximately 340 g/mol. GHK-Cu is that same tripeptide holding a coordinated copper(II) ion, commonly cited at approximately 403.9 g/mol — the roughly 64-unit difference being the metal. Much of the published research examines the copper complex specifically and attributes the observed behaviour to the complex rather than to the peptide alone, so the two should not be treated as interchangeable when sourcing material or reading results.

Why is GHK-Cu blue, and does the colour indicate quality? The blue arises from a d-d electronic absorption of the coordinated copper, with an absorbance maximum in the red-orange region near 600 nm; because red light is absorbed, the material appears blue. That makes colour a convenient informal integrity cue — a vivid blue is consistent with an intact complex, while fading, a shift toward green, or a drift to brown is consistent with a change in the complex. It is a qualitative indicator only, not a substitute for chromatographic and spectrometric testing.

References & further reading

Related research

TB-500 (Thymosin Beta-4 Fragment)→ Peptide Storage and Stability→ How to Read a Peptide COA→

For Research Use Only. All Aminent Labs materials are intended solely for in-vitro research and laboratory use — not for human or veterinary use. View the product page, browse the catalog, or review certificates of analysis.